For millions of people worldwide, a perceived change in light, altered vision, nausea and even hallucinations are just a few of the potential early onset symptoms of a migraine. Here is a brief overview of this neurological syndrome and how cannabidiol (CBD) can potentially alleviate the throbbing (and often excruciating) pain experienced by migraine sufferers.
What is a migraine?
According to the National Institute of Neurological Disorders and Stroke, “migraines are typically moderate to severe headaches that only affect one side of the head. They usually come on very suddenly and are described as throbbing or pounding headaches.”
Though the exact cause of migraines are still unknown, research published by the Migraine Research Foundation states that the cause of a migraine is due to a disorder in the nerve pathways and brain chemicals. Furthermore, studies have shown the disorder is linked to genes. Therefore, genetics play a factor.
According to statistics published in 2011 by Health Canada, approximately 2.7 million Canadians reported that they had been diagnosed with a migraine.
CBD Oil and Migraines
In 1990, researchers at the National Institute of Mental Health in Bethesda, MD, published the first study indicating that the brain contains cannabinoid receptors. In subsequent years, this group of receptors or portals came to be known as the endocannabinoid system, which according to research published in 2009 by the Department of Psychology at the University of Georgia, is “where the brain produces and processes endocannabinoids, the brain’s own cannabis-like substances. Endocannabinoids are thought to be responsible for regulating inflammation and pain sensation.” A study conducted by researchers at the Neuroscience Institute of Alicante, speaks about the effects of cannabidiol (CBD), a principal component of the cannabis plant and the second highest abundant in cannabinoids. According to the study, “cannabidiol has well-documented biological effects of potential therapeutic interest, such as anti-anxiety, anti-convulsive, anti-nausea, anti-inflammatory and anti-tumor properties.”
In 2010, the first study showing a link between the endocannabinoid system (ECS) and migraines was published by the IRCCS Neurological Institute. The findings corroborated the research from the Neuroscience Institute of Alicante. In addition, the IRCCS study suggested that “activation of ECS could represent a promising therapeutic tool for reducing both the physiological and inflammatory components of pain that are likely involved in migraine attacks.”
Since medical cannabis was first made accessible to Canadians in 2014, thousands of migraine sufferers have chosen high CBD medical cannabis strains as an alleviant for their migraine symptoms.
When it comes to CBD oil, our preferred licensed producer is CannTrust, which offers the ONLY pharmaceutically STANDARDIZED oral solution for patients who prefer not to smoke their medical cannabis. Migraine sufferers interested in trying CannTrust’s new CBD Drops should call 1-855-794-2266.
For help with medical cannabis licensing or to sign up for a free medical cannabis consultation, please register on our website using the promo code CBD710.